scispace - formally typeset
Open AccessJournal ArticleDOI

Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study.

Reads0
Chats0
TLDR
Chemosensitive disturbances persisted in 7.2 per cent of patients 60 days after clinical onset and specific therapies should be initiated in patients with severe olfactory and gustatory disturbances 20 days after disease onset.
Abstract
Background The long-term recovery rate of chemosensitive functions in coronavirus disease 2019 patients has not yet been determined. Method A multicentre prospective study on 138 coronavirus disease 2019 patients was conducted. Olfactory and gustatory functions were prospectively evaluated for 60 days. Results Within the first 4 days of coronavirus disease 2019, 84.8 per cent of patients had chemosensitive dysfunction that gradually improved over the observation period. The most significant increase in chemosensitive scores occurred in the first 10 days for taste and between 10 and 20 days for smell. At the end of the observation period (60 days after symptom onset), 7.2 per cent of the patients still had severe dysfunctions. The risk of developing a long-lasting disorder becomes significant at 10 days for taste (odds ratio = 40.2, 95 per cent confidence interval = 2.204–733.2, p = 0.013) and 20 days for smell (odds ratio = 58.5, 95 per cent confidence interval = 3.278–1043.5, p = 0.005). Conclusion Chemosensitive disturbances persisted in 7.2 per cent of patients 60 days after clinical onset. Specific therapies should be initiated in patients with severe olfactory and gustatory disturbances 20 days after disease onset.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Long covid-mechanisms, risk factors, and management.

TL;DR: In this article, a review summarizes studies of the long term effects of covid-19 in hospitalized and non-hospitalized patients and describes the persistent symptoms they endure, including fatigue, dyspnea, cardiac abnormalities, cognitive impairment, sleep disturbances, symptoms of posttraumatic stress disorder, muscle pain, concentration problems, and headache.
Journal ArticleDOI

Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review.

TL;DR: More than half of COVID-19 survivors experienced persistent postacute sequelae (PASC) 6 months after recovery as mentioned in this paper, and most common PASC involved functional mobility impairments, pulmonary abnormalities, and mental health disorders.
Journal ArticleDOI

Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.

TL;DR: A systematic review of studies examining the frequency and variety of persistent symptoms after COVID-19 infection was conducted by as mentioned in this paper, where the authors defined persistent symptoms as those persisting for at least 60 days after diagnosis, symptom onset, or hospitalization or at least 30 days after recovery from the acute illness or hospital discharge.
Journal ArticleDOI

Gustatory Dysfunction: A Highly Specific and Smell-Independent Symptom of COVID-19

TL;DR: According to the psychophysical evaluations, it can be inferred that the pathogenesis of taste disorders in COVID-19 patients is largely smell-independent, and it is essential that gustatory dysfunctions, like olfactory disorders, are included in the CO VID-19 guidelines.
References
More filters
Journal ArticleDOI

Smell dysfunction: a biomarker for COVID-19.

TL;DR: Severe acute respiratory syndrome‐coronavirus‐2 (SARS‐CoV‐2), the virus that causes coronavirus disease 2019 (COVID‐19), is responsible for the largest pandemic since the 1918 influenza A virus subtype H1N1 influenza outbreak.
Journal ArticleDOI

Anosmia and Ageusia: Common Findings in COVID-19 Patients.

TL;DR: In a not negligible number of patients affected by COVID‐19 (coronavirus disease 2019), especially if paucisymptomatic, anosmia and ageusia can represent the first or only symptomatology present, it is necessary to select patients suitable for surgery on the basis of prior history and once they provide informed consent for surgery.
Journal ArticleDOI

Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection.

TL;DR: This study reports on the prevalence, intensity, and timing of an altered sense of smell or taste in patients with SARS-CoV-2 infections.
Related Papers (5)